These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 2445406)

  • 1. Direct activation of Ca2+ channels by palmitoyl carnitine, a putative endogenous ligand.
    Spedding M; Mir AK
    Br J Pharmacol; 1987 Oct; 92(2):457-68. PubMed ID: 2445406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.
    Spedding M; Berg C
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov; 328(1):69-75. PubMed ID: 6083458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of palmitoyl carnitine with calcium antagonists in myocytes.
    Patmore L; Duncan GP; Spedding M
    Br J Pharmacol; 1989 Jun; 97(2):443-50. PubMed ID: 2474346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competitive interactions between Bay K 8644 and nifedipine in K+ depolarized smooth muscle: a passive role for Ca2+?
    Spedding M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):464-6. PubMed ID: 2581150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective antagonism of calcium channel activators by fluspirilene.
    Kenny BA; Fraser S; Kilpatrick AT; Spedding M
    Br J Pharmacol; 1990 Jun; 100(2):211-6. PubMed ID: 1696149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.
    Spedding M
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):234-40. PubMed ID: 7063049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues.
    Nakaya H; Hattori Y; Tohse N; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
    Kenny BA; Fraser S; Spedding M
    Br J Pharmacol; 1993 Jan; 108(1):93-9. PubMed ID: 7679034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of phorbol esters with Ca2+ channels in smooth muscle.
    Spedding M
    Br J Pharmacol; 1987 Jun; 91(2):377-84. PubMed ID: 2440506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing surface charge with salicylate differentiates between subgroups of calcium-antagonists.
    Spedding M
    Br J Pharmacol; 1984 Sep; 83(1):211-20. PubMed ID: 6487889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.
    Nokin P; Clinet M; Polster P; Beaufort P; Meysmans L; Gougat J; Chatelain P
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):31-6. PubMed ID: 2542806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of the dihydropyridine Bay K 8644 in guinea-pig isolated trachealis.
    Allen SL; Foster RW; Small RC; Towart R
    Br J Pharmacol; 1985 Sep; 86(1):171-80. PubMed ID: 2413935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
    Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
    Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of palmitoyl carnitine with the endothelium in rat aorta.
    Dainty IA; Bigaud M; McGrath JC; Spedding M
    Br J Pharmacol; 1990 Jun; 100(2):241-6. PubMed ID: 1696151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Ca2+ channel antagonists in guinea-pig normal and skinned gall bladder.
    Cejalvo D; Calvo MA; Lloris JM; Cortijo J; Morcillo EJ
    Eur J Pharmacol; 1993 Mar; 234(1):23-8. PubMed ID: 8472758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interactions of calcium-antagonists in K+-depolarized smooth muscle.
    Spedding M
    Br J Pharmacol; 1983 Nov; 80(3):485-8. PubMed ID: 6640202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
    Rogg H; Criscione L; Truog A; Meier M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S31-7. PubMed ID: 2414592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
    Carvalho CA; Coutinho OP; Carvalho AP
    J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.